|Systematic (IUPAC) name|
|Mol. mass||365.336 g/mol|
|(what is this?)|
Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. It is marketed in France under the trade name Octoplus and in Italy as Gramplus.
It penetrates into human lung tissue.
- "Gramplus" (in Italian). Studio Medico Torrino. July 25, 2007. Retrieved 2007-08-10.
- Combe J, Simonnet F, Yablonsky F, Simonnet G (1980). "[Clofoctol binding by the bacteria (author's transl)]". J Pharmacol (in French) 11 (4): 411–25. PMID 6782374.
- Danesi R, Gasperini M, Senesi S, Freer G, Angeletti CA, Del Tacca M (1988). "A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay". Drugs Exp Clin Res 14 (1): 39–43. PMID 3391105.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|